High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma

[1]  Dong Han Lee,et al.  High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma , 2013, Radiation Oncology.

[2]  Dong Han Lee,et al.  Severe intestinal toxicity after stereotactic ablative radiotherapy for abdominopelvic malignancies , 2013, International Journal of Colorectal Disease.

[3]  Zahra Kassam,et al.  Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  S. Kang,et al.  Changes of the liver volume and the Child-Pugh score after high dose hypofractionated radiotherapy in patients with small hepatocellular carcinoma , 2012, Radiation oncology journal.

[5]  Dong Han Lee,et al.  Predictor of severe gastroduodenal toxicity after stereotactic body radiotherapy for abdominopelvic malignancies. , 2012, International journal of radiation oncology, biology, physics.

[6]  Dong Han Lee,et al.  Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization , 2012, Cancer.

[7]  F. Xia,et al.  A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. , 2012, Journal of hepatology.

[8]  Y. Jen,et al.  Stereotactic body radiation therapy in recurrent hepatocellular carcinoma. , 2012, International journal of radiation oncology, biology, physics.

[9]  Ryosuke Tateishi,et al.  nature publishing group ORIGINAL CONTRIBUTIONS 569 CME Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors LIVER , 2022 .

[10]  Cynthia S. Johnson,et al.  Stereotactic body radiotherapy for primary hepatocellular carcinoma. , 2011, International journal of radiation oncology, biology, physics.

[11]  T. Lacornerie,et al.  Stereotactic Radiotherapy of Hepatocellular Carcinoma: Preliminary Results , 2010, Technology in cancer research & treatment.

[12]  Dong Han Lee,et al.  Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma , 2010, Journal of surgical oncology.

[13]  Andrea Bezjak,et al.  Stereotactic body radiation therapy for inoperable early stage lung cancer. , 2010, JAMA.

[14]  R. T. Ten Haken,et al.  Radiation-associated liver injury. , 2010, International journal of radiation oncology, biology, physics.

[15]  N. Toyota,et al.  Percutaneous radiofrequency ablation as first‐line treatment for small hepatocellular carcinoma: Results and prognostic factors on long‐term follow up , 2010, Journal of gastroenterology and hepatology.

[16]  Riccardo Lencioni,et al.  Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma , 2010, Seminars in liver disease.

[17]  Samuel Ryu,et al.  American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. , 2004, International journal of radiation oncology, biology, physics.

[18]  T. López-Cuadrado,et al.  Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma , 2009, BMC gastroenterology.

[19]  L. Gaspar,et al.  Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  W. Franklin,et al.  Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  L. Mariani,et al.  Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. , 2009, The Lancet. Oncology.

[22]  Mitsuhiro Nakamura,et al.  Geometrical differences in target volumes between slow CT and 4D CT imaging in stereotactic body radiotherapy for lung tumors in the upper and middle lobe. , 2008, Medical physics.

[23]  David D. Smith,et al.  Trends in local therapy for hepatocellular carcinoma and survival outcomes in the US population. , 2008, American journal of surgery.

[24]  Maria Hawkins,et al.  Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Jae-Hong Park,et al.  Distortion of the Dose Profile in a Three-dimensional Moving Phantom to Simulate Tumor Motion during Image-guided Radiosurgery. , 2007 .

[26]  E. Kunieda,et al.  Small lung tumors: long-scan-time CT for planning of hypofractionated stereotactic radiation therapy--initial findings. , 2005, Radiology.

[27]  T. Kawabe,et al.  A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. , 2005, Gastroenterology.

[28]  M. Choi,et al.  Local radiotherapy for patients with unresectable hepatocellular carcinoma. , 2005, International journal of radiation oncology, biology, physics.

[29]  J. Seong,et al.  Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: a retrospective study of 158 patients. , 2003, International journal of radiation oncology, biology, physics.

[30]  J. Bruix,et al.  Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival , 2003, Hepatology.

[31]  Daniel Normolle,et al.  Analysis of radiation-induced liver disease using the Lyman NTCP model. , 2002, International journal of radiation oncology, biology, physics.

[32]  C. Suh,et al.  Dose-response relationship in local radiotherapy for hepatocellular carcinoma. , 2001, International journal of radiation oncology, biology, physics.

[33]  D. Hussey.  American Society for Therapeutic Radiology and Oncology , 2001 .

[34]  M. Makuuchi,et al.  Results of surgical and nonsurgical treatment for small‐sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan , 2000, Hepatology.

[35]  R. T. Ten Haken,et al.  Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[37]  N. Moriyama,et al.  Therapeutic results of resection, transcatheter arterial embolization and percutaneous transhepatic ethanol injection in 3225 patients with hepatocellular carcinoma: a retrospective multicenter study. , 1997, Japanese journal of clinical oncology.

[38]  M. Anscher,et al.  Hepatic toxicity resulting from cancer treatment. , 1995, International journal of radiation oncology, biology, physics.

[39]  G J Kutcher,et al.  Analysis of clinical complication data for radiation hepatitis using a parallel architecture model. , 1995, International journal of radiation oncology, biology, physics.

[40]  I. Lax,et al.  Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. , 1995, Acta oncologica.

[41]  M Goitein,et al.  Strategies for treating possible tumor extension: some theoretical considerations. , 1985, International journal of radiation oncology, biology, physics.

[42]  G. B. Reed,et al.  RADIATION HEPATITIS. , 1965, The American journal of roentgenology, radium therapy, and nuclear medicine.